SEC Form 4 · accession 0001127602-17-026484
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Kraeutler
Officer — Chairman and CEO · Director
Period of report
Aug 24, 2017
Accepted (ET)
Aug 25, 2017 · 12:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 24, 2017 | P | 7,000 | $13.6705 | A | 345,230 | D | |
| Common Stock | holding | — | — | — | 761 | I | Held in Meridian Savings & Investment Plan (401K) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prices range from $13.6637 per share to $13.6750 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.